References
- Dacie JV. The Haemolytic Anemias (Volumes 1–5). Churchill Livingstone, New York, NY, USA (1985–1995).
- Summerfield GP, Wyatt GP. Human parvovirus infection revealing hereditary spherocytosis. Lancet 2(8463), 1070 (1985).
- Bratosin D, Mazurier J, Tissier JP et al. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages: a review. Biochimie 80(2), 173–195 (1998).
- Genty I, Michel M, Hermine O, Schaeffer A, Godeau B, Rochant H. Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases. Rev. Med. Interne. 23(11), 901–909 (2002).
- Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 243(19), 1909–1911 (1980).
- Bain BJ. Diagnosis from the blood smear. N. Engl. J. Med. 353, 498–507 (2005).
- Coombs RRA, Mourant AE, Race RR. In vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1, 264–266 (1946).
- Das SS, Chaudhary R, Khetan D. A comparison of conventional tube test and gel technique in evaluation of direct antiglobulin test. Hematology 12(2), 175–178 (2007).
- Habibi B, Muller A, Lelong F et al. Red cell autoimmunization in a “normal” population. 63 cases. Nouv. Presse Med. 9(43), 3253–3257 (1980).
- Garratty G. The significance of IgG on the red cell surface. Transfus. Med. Rev. 1(1), 47–57 (1987).
- Freedman J, Barefoot C. Red blood cell-bound C3d in normal subjects and in random hospital patients. Transfusion 22(6), 511–514 (1982).
- Hodgson K, Ferrer G, Montserrat E, Moreno C. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica 96(5), 752–761 (2011).
- Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am. J. Hematol. 69(4), 258–271 (2002).
- Garratty G. Immune hemolytic anemia associated with negative routine serology. Semin. Hematol. 42(3), 156–164 (2005).
- Kamesaki T, Oyamada T, Omine M, Ozawa K, Kajii E. Cutoff value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Am. J. Hematol. 84(2), 98–101 (2009).
- Petz LD, Garratty G. Immune Hemolytic Anemias (2nd Edition). Churchill Livingstone, PA, USA (2004).
- Noizat-Pirenne F, Tournamille C. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin. Biol. 18(5–6), 527–535 (2011).
- Chadebech P, Michel M, Janvier D et al. IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI. Blood 116(20), 4141–4147 (2010).
- Barros MM, Blajchman MA, Bordin JO. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Transfus. Med. Rev. 24(3), 195–210 (2010).
- Garbe E, Andersohn F, Bronder E et al. Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. Br. J. Haematol. 154(5), 644–653 (2011).
- Garratty G. Drug-induced immune hemolytic anemia. Hematology Am. Soc. Hematol. Educ. Program 73–79 (2009).
- Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin. Hematol. 42(3), 137–144 (2005).
- Shapira Y, Vaturi M, Sagie A. Hemolysis associated with prosthetic heart valves: a review. Cardiol. Rev. 17(3), 121–124 (2009).
- Mestres CA, Soo CS, Sim EK, Adebo OA, Yan P, Lee CN. Intravascular hemolysis after mitral valve repair: a word of caution. Eur. J. Cardiothorac. Surg. 6(2), 103–105 (1992).
- Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 112(1), 11–18 (2008).
- Patel A, Patel H, Patel A. Thrombotic thrombocytopenic purpura: the masquerader. South Med. J. 102(5), 504–509 (2009).
- Jordan J, Kiernan W, Merker HJ, Wenzel M, Beneke R. Red cell membrane skeletal changes in marathon runners. Int. J. Sports Med. 19(1), 16–19 (1998).
- Vasudev M, Bresnahan BA, Cohen EP, Hari PN, Hariharan S, Vasudev BS. Percussion hemoglobinuria – a novel term for hand trauma-induced mechanical hemolysis: a case report. J. Med. Case Reports 5(1), 508 (2011).
- Jubault V, De Lacroix-Szmania I, Zittoun J et al. Hemolysis and schizocytosis, malabsorption and the “folate trap”: unusual semiological peculiarities associated with vitamin B12 deficiency. Rev. Med. Interne. 19(12), 921–923 (1998).
- An X, Mohandas N. Disorders of red cell membrane. Br. J. Haematol. 141(3), 367–375 (2008).
- Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ. Guidelines for the diagnosis and management of hereditary spherocytosis. Br. J. Haematol. 126(4), 455–474 (2004).
- Zanella A, Izzo C, Rebulla P, Zanuso F, Perroni L, Sirchia G. Acidified glycerol lysis test: a screening test for spherocytosis. Br. J. Haematol. 45(3), 481–486 (1980).
- Streichman S, Gescheidt Y. Cryohemolysis for the detection of hereditary spherocytosis: correlation studies with osmotic fragility and autohemolysis. Am. J. Hematol. 58(3), 206–212 (1998).
- Girodon F, Garcon L, Bergoin E et al. Usefulness of the eosin-5′-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br. J. Haematol. 140(4), 468–470 (2008).
- Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood 112(10), 3939–3948 (2008).
- Stewart GW, O’Brien H, Morris SA, Owen JS, Lloyd JK, Ames JA. Stomatocytosis, abnormal platelets and pseudo-homozygous hypercholesterolaemia. Eur. J. Haematol. 38(4), 376–380 (1987).
- Allen DW, Manning N. Abnormal phospholipid metabolism in spur cell anemia: decreased fatty acid incorporation into phosphatidylethanolamine and increased incorporation into acylcarnitine in spur cell anemia erythrocytes. Blood 84(4), 1283–1287 (1994).
- Doll DC, Doll NJ. Spur cell anemia. South Med. J. 75(10), 1205–1210 (1982).
- Prokocimer M, Potasman I. The added value of peripheral blood cell morphology in the diagnosis and management of infectious diseases – part 1: basic concepts. Postgrad. Med. J. 84(997), 579–585 (2008).
- Potasman I, Prokocimer M. The added value of peripheral blood cell morphology in the diagnosis and management of infectious diseases – part 2: illustrative cases. Postgrad. Med. J. 84(997), 586–589 (2008).
- Steinberg MH. In the clinic. Sickle cell disease. Ann. Intern. Med. 155(5), ITC31–ITC15; quiz ITC316 (2011).
- De Latour RP, Mary JY, Salanoubat C et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112(8), 3099–3106 (2008).
- Borowitz M, Craig FE, Digiuseppe JA et al. Clinical Cytometry Society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin. Cytom. 78(4), 211–230 (2010).
- Jaffe ER. Hereditary hemolytic disorders and enzymatic deficiencies of human erythrocytes. Blood 35(1), 116–134 (1970).
- Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371(9606), 64–74 (2008).
- Au WY, Lam V, Pang A et al. Glucose-6-phosphate dehydrogenase deficiency in female octogenarians, nanogenarians, and centenarians. J. Gerontol. A Biol. Sci. Med. Sci. 61(10), 1086–1089 (2006).
- Prchal JT, Gregg XT. Red cell enzymes. Hematology Am. Soc. Hematol. Educ. Program 19–23 (2005).
- Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br. J. Haematol. 130(1), 11–25 (2005).
- Cunningham MJ. Update on thalassemia: clinical care and complications. Hematol. Oncol. Clin. North Am. 24(1), 215–227 (2010).
- Taher AT, Musallam KM, Cappellini MD, Weatherall DJ. Optimal management of β-thalassaemia intermedia. Br. J. Haematol. 152(5), 512–523 (2011).
- Rund D, Rachmilewitz E. β-Thalassemia. N. Engl. J. Med. 353(11), 1135–1146 (2005).
- Williamson D. The unstable haemoglobins. Blood Rev. 7(3), 146–163 (1993).
- Papanikolaou NC, Hatzidaki EG, Belivanis S, Tzanakakis GN, Tsatsakis AM. Lead toxicity update. A brief review. Med. Sci. Monit. 11(10), RA329–RA336 (2005).
- Michel M, Lafaurie M, Noel V et al. Hemolytic anemia disclosing Wilson’s disease. Report of 2 cases. Rev. Med. Interne. 22(3), 280–283 (2001).
- Romeo L, Apostoli P, Kovacic M, Martini S, Brugnone F. Acute arsine intoxication as a consequence of metal burnishing operations. Am. J. Ind. Med. 32(3), 211–216 (1997).
- Reid HA. Cobra-Bites. Br. Med. J. 2(5408), 540–545 (1964).
- Vachvanichsanong P, Dissaneewate P, Mitarnun W. Non-fatal acute renal failure due to wasp stings in children. Pediatr. Nephrol. 11(6), 734–736 (1997).
- Shichishima T, Ikeda K, Takahashi N et al. Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes. Int. J. Hematol. 91(4), 602–610 (2010).